<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02965339</url>
  </required_header>
  <id_info>
    <org_study_id>RNI2015-05 (PI2015-05)</org_study_id>
    <nct_id>NCT02965339</nct_id>
  </id_info>
  <brief_title>Evaluation of the Association Between Pre-existing Endothelial Dysfunction and the Onset of Vasoplegia During Cardiac Surgery With Cardiopulmonary Bypass</brief_title>
  <acronym>DYVA</acronym>
  <official_title>Evaluation of the Association Between Pre-existing Endothelial Dysfunction and the Onset of Vasoplegia During Cardiac Surgery With Cardiopulmonary Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac surgery patients have many risk factors for endothelial dysfunction (hypertension,
      atherosclerosis, dyslipidemia, chronic renal failure ...).

      It is likely that a significant number of patients suffering from a preexisting endothelial
      dysfunction. This endothelial dysfunction can be assessed by a molecular approach
      (determination of NO, ICAM1, VCAM1, IL8, endothelial microparticles ...). Extracorporeal
      circulation with ischemia-reperfusion causes a breach of particularly important glycocalyx as
      ischemia-reperfusion injury is. No studies have evaluated the time course of the
      infringement, and its association with the immediate post-operative complications (SIRS,
      coagulopathy, vasoplegic syndrome, renal failure). Only one study has regained an association
      between endothelial dysfunction during cardiac bypass surgery and postoperative cardiac
      surgery vasoplegic syndrome. A study in noncardiac surgery has regained an association
      between endothelial dysfunction (assessed by a vasoplegia test) and postoperative acute renal
      failure. Thus there is some data in the literature to suggest that the occurrence of
      postoperative complications (SIRS, coagulopathy, capillary leak syndrome, acute circulatory
      failure vasoplegic and acute renal failure) may result from the interaction between a
      pre-existing endothelial dysfunction and &quot;operative&quot; aggression (extracorporeal circulation).
      The onset of complications result from an interaction that depends on the importance of
      endothelial dysfunction at baseline.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The primary endpoint was the occurrence of vasoplegic syndrome</measure>
    <time_frame>6 months</time_frame>
    <description>The primary endpoint was the occurrence of vasoplegic syndrome correlate with markers of endothelial function following: IL8, P-selectin, von Willebrand factor precursor.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of vasoplegic syndrome</measure>
    <time_frame>6 months</time_frame>
    <description>Occurrence of vasoplegic syndrome correlate with markers of endothelial function following: endothelial microparticles, Von Willebrand factor, VCAM1.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Marker of degradation glycocalyx:</measure>
    <time_frame>6 months</time_frame>
    <description>Marker of degradation glycocalyx: syndecan, heparan sulfate.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory markers:</measure>
    <time_frame>6 months</time_frame>
    <description>Inflammatory markers: leukocytes, CRP, procalcitonin, albumin, TNF alpha, IL-10, IL-6, IL1beta</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Markers of blood coagulation</measure>
    <time_frame>6 months</time_frame>
    <description>Markers of blood coagulation: Platelet count, PT, APTT, fibrinogen, D dimers, soluble complexes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>6 months</time_frame>
    <description>Complications: cardiovascular (vasoplegic syndrome), kidney (KDIGO).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>6 months</time_frame>
    <description>Death</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Vasoplegia</condition>
  <condition>Endothelial Dysfunction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients ≥ 18 years, operated on for cardiac surgical myocardial revascularization (CABG)
        or surgical correction of aortic valve.

        Consent signed.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients ≥ 18 years.

          -  Patient operated on for cardiac surgical myocardial revascularization (CABG) or
             surgical correction of aortic valve.

          -  Consent signed.

        Exclusion Criteria:

          -  Standing arrhythmia.

          -  Pregnant woman.

          -  curative anticoagulation (warfarin, NANCO, heparin).

          -  Patient under guardianship.

          -  Patient Refused to participate.

          -  Cardiac surgery without CPB.

          -  bicuspid aortic valve.

          -  Participation in another study.

          -  preoperative sepsis.

          -  Minor or major, under guardianship or trusteeship (art L1121-5, L1121-8 and L1122 1-2)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre-Grégoire GUINOT, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens Picardie</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre-Grégoire GUINOT, Doctor</last_name>
    <phone>3 22 08 79 80</phone>
    <phone_ext>+33</phone_ext>
    <email>guinot.pierre-gregoire@chu-amiens.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mohamed AIT AMER MEZIANE, PHD</last_name>
    <phone>3.22.08.83.84</phone>
    <phone_ext>+33</phone_ext>
    <email>aitamermeziane.mohamed@chu-amiens.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU De Caen</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc-Olivier Fischer</last_name>
    </contact>
    <investigator>
      <last_name>Marc-Olivier Fischer, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2016</study_first_submitted>
  <study_first_submitted_qc>November 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2016</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vasoplegia</keyword>
  <keyword>endothelial dysfunction</keyword>
  <keyword>extracorporeal circulation</keyword>
  <keyword>cardiac surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vasoplegia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

